Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Chlamydia Screening in Women (CHL)

CBE ID
0033
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Spring 2027
1.6 Measure Description

The percentage of women 16–24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      No
      1.8 Level of Analysis
      1.20 Types of Data Sources
      1.14 Numerator

      Women who were tested for chlamydia during the measurement year.

      1.15 Denominator

      Women 16-24 years of age who had a claim or encounter indicating sexual activity.

      Exclusions

      Women who received a pregnancy test to determine contraindications for medication (isotretinoin) or x-ray.
      Women who were in hospice or using hospice services during the measurement year.

      1.13 Data Dictionary
      Not attached. I attest that all information will be provided where codes and/or value sets are needed (1.14a - 1.15c).
      Most Recent Endorsement Activity
      Endorsed Perinatal and Women's Health Spring 2021
      Initial Endorsement
      Last Updated
      Steward Organization
      National Committee for Quality Assurance
      Steward POC email
      Steward Organization Copyright

      ©2021 by the National Committee for Quality Assurance 
      1100 13th Street, NW, Suite 1000 
      Washington, DC 20005

                Public Comments